Aviva shares yield 8%+. Should investors buy?

Aviva shares currently sport a monster dividend yield. Should investors buy the insurance stock for passive income, or is this a trap?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Aviva (LSE: AV.) shares have fallen this year. As a result, they now sport a dividend yield of more than 8%.

Is this a great opportunity for those seeking dividend income? Let’s discuss.

Aviva is in good shape

Aviva appears to be in solid shape right now. In recent years, the insurer has undergone a massive transformation programme under CEO Amanda Blanc, and this appears to be bearing fruit.

For the first quarter of 2023, for example, the company posted an 11% rise in general insurance premiums, while health insurance sales rose 25% as more individuals and businesses opted for private cover.

We have delivered an encouraging start to 2023 and continue to build clear trading momentum. New business volumes are good, despite persistent economic uncertainty, and we delivered another quarter of strong growth across our diversified business,” said Blanc.

Looking ahead, the CEO was confident that the company can continue to deliver.

We have market leading positions in high growth areas. We are financially strong with an attractive and growing dividend, and we are confident in the prospects for Aviva,” she added.

This is all very encouraging. Unlike some other high yielders (e.g. tobacco companies), this doesn’t appear to be a company that’s facing major challenges.

Dividend analysis

As for the dividend, it looks sustainable in the near term. Currently, analysts expect the insurer to pay out 33.6p per share this year from earnings per share of 54.5p.

That gives a dividend coverage ratio of around 1.6, which is relatively healthy. And in the recent trading update, the company said that it’s aiming for “low-to-mid single-digit growth” in the cash cost of the dividend beyond 2023.

It’s worth noting that dividends are not the only form of capital returns here. Recently, Aviva has been buying back its own shares.

Last month, it completed its £300m share buyback programme, acquiring roughly 72.8m shares at an average price of 412p per share. Share buybacks tend to boost earnings per share over time, making a stock more attractive from a valuation perspective.


Speaking of valuation, Aviva’s is really low right now. That forecast earnings figure of 54.5p per share I mentioned gives the stock a forward-looking P/E ratio of just 7.3. That’s well below the FTSE 100 average.


As for the risks, there are a few to be aware of here. One is that Aviva has a patchy long-term dividend track record. It has been known to slash its payouts when profits fall.

So there’s no guarantee the company will continue to pay massive dividends.

Another is higher interest rates. This could have a negative impact on the values of fixed-income assets on the company’s balance sheet and hit its profits.

A third risk is a spike in health insurance claims costs. Recently, several US insurers have reported higher costs following an increase in post-Covid surgeries.

On balance though, I think Aviva looks interesting from an income investing perspective. If generating income was my goal, I would definitely consider an investment here.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young black female footballer training on stadium pitch
Investing Articles

My JD Sports Fashion share price prediction for the second half of 2024

The JD Sports Fashion share price hasn't yet recovered from January’s slump. So will the retailer's stock bounce back in…

Read more »

Investing Articles

Up 47% in a week! Can the Capita share price continue to rocket?

The Capita share price has smashed the market in the last week, and Harvey Jones wonders whether it has the…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

What could the second half of 2024 have in store for the BAE Systems share price?

After a strong first six months of the year, what could be coming next for the BAE Systems share price?…

Read more »

Growth Shares

2 FTSE 100 stocks that are outperforming these MAG7 members

Jon Smith reveals some FTSE 100 stocks that offer him a viable alternative to the Magnificent 7, based on recent…

Read more »

Investing Articles

My Scottish Mortgage shares just paid me £14.88. It’s another step towards making a million

Harvey Jones has just received a measly dividend from his Scottish Mortgage shares, but he's got big, big plans for…

Read more »

Investing Articles

FTSE 100 shares: is Barclays a standout buy?

Barclays shares are among the FTSE 100's top performers and this Fool thinks they have further to go. He explains…

Read more »

Black woman using loudspeaker to be heard
Investing For Beginners

At 52-week highs, here’s what may be next for the Lloyds share price

Jon Smith notes the strong rally in the Lloyds share price in the recent past and explains why the good…

Read more »

Young Asian woman with head in hands at her desk
Investing Articles

These UK shares are stinking out my ISA. Time to sell?

Paul Summers has been reviewing some of the worst-performing UK shares in his portfolio. Has the time finally come to…

Read more »